Literature DB >> 32886534

Multimodality imaging review of complex pelvic lesions in female pelvis.

Anuradha Chandramohan1, Tameem Ahmed Bhat1, Reetu John1, Betty Simon1.   

Abstract

Complex pelvic lesions can originate from various anatomical structures in the pelvis and pose a diagnostic dilemma due to a wide range of possible diagnoses. Accurate characterisation of these lesions would often require an algorithmic approach, which incorporates clinical findings, sequential use of multiple imaging modalities and a multiparametric approach. This approach usually aims at identifying key imaging features, which aid in anatomical localisation, morphology and tissue characterisation. There have been various attempts to standardise the lexicon used for describing adnexal masses in female patients; stratify their risk of cancer and suggest appropriate next steps in the management pathway. Through this review, we extend this approach to complex pelvic masses in female pelvis in general and will focus on optimal use of different imaging modalities to arrive at definitive diagnosis or meaningful differential diagnosis. We will also discuss potential pitfalls of imaging diagnosis and common mimics.

Entities:  

Mesh:

Year:  2020        PMID: 32886534      PMCID: PMC7716001          DOI: 10.1259/bjr.20200489

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  61 in total

1.  Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses.

Authors:  Isabelle Thomassin-Naggara; Emile Daraï; Charles A Cuenod; Laure Fournier; Irwin Toussaint; Claude Marsault; Marc Bazot
Journal:  Eur Radiol       Date:  2009-02-13       Impact factor: 5.315

2.  Radiological predictors of complete cytoreduction in 59 patients with peritoneal mesothelioma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a UK referral centre.

Authors:  Anuradha Chandramohan; Andrew Thrower; Nehal Shah; Faheez Mohamed
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

3.  Sclerosing stromal tumor of the ovary: radiologic findings.

Authors:  R Matsubayashi; Y Matsuo; J Doi; S Kudo; K Matsuguchi; H Sugimori
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 4.  Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.

Authors:  Erin F Wolff; Marybeth Hughes; Maria J Merino; James C Reynolds; Jeremy L Davis; Craig S Cochran; Francesco S Celi
Journal:  Thyroid       Date:  2010-09       Impact factor: 6.568

5.  MRI features of ovarian fibroma and fibrothecoma with histopathologic correlation.

Authors:  Atul B Shinagare; Liesbeth J Meylaerts; Anna R Laury; Koenraad J Mortele
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

Review 6.  Recognition of the ovaries and ovarian origin of pelvic masses with CT.

Authors:  Faysal A Saksouk; Samuel C Johnson
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

7.  Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas.

Authors:  Abdellatif Chechia; Leila Attia; Riadh Ben Temime; Taher Makhlouf; Abdelhamid Koubaa
Journal:  Am J Obstet Gynecol       Date:  2008-05-23       Impact factor: 8.661

8.  Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions.

Authors:  Shinya Fujii; Suguru Kakite; Keisuke Nishihara; Yoshiko Kanasaki; Tasuku Harada; Junzo Kigawa; Toshio Kaminou; Toshihide Ogawa
Journal:  J Magn Reson Imaging       Date:  2008-11       Impact factor: 4.813

9.  Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign.

Authors:  Michael T Corwin; Eugenio O Gerscovich; Ramit Lamba; Machelle Wilson; John P McGahan
Journal:  Radiology       Date:  2013-11-13       Impact factor: 11.105

10.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Authors:  Ian J Jacobs; Usha Menon; Andy Ryan; Aleksandra Gentry-Maharaj; Matthew Burnell; Jatinderpal K Kalsi; Nazar N Amso; Sophia Apostolidou; Elizabeth Benjamin; Derek Cruickshank; Danielle N Crump; Susan K Davies; Anne Dawnay; Stephen Dobbs; Gwendolen Fletcher; Jeremy Ford; Keith Godfrey; Richard Gunu; Mariam Habib; Rachel Hallett; Jonathan Herod; Howard Jenkins; Chloe Karpinskyj; Simon Leeson; Sara J Lewis; William R Liston; Alberto Lopes; Tim Mould; John Murdoch; David Oram; Dustin J Rabideau; Karina Reynolds; Ian Scott; Mourad W Seif; Aarti Sharma; Naveena Singh; Julie Taylor; Fiona Warburton; Martin Widschwendter; Karin Williamson; Robert Woolas; Lesley Fallowfield; Alistair J McGuire; Stuart Campbell; Mahesh Parmar; Steven J Skates
Journal:  Lancet       Date:  2015-12-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.